Allyson Cole-Strauss

Department of Translational Neuroscience, Michigan State University

Affiliated withMichigan State University

Research Area

Biography

Allyson Cole-Strauss has not added Biography.
If you are Allyson Cole-Strauss and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2022

Other Publications

Article	Year
Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine Model. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22008908	2011
Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex. Journal of Parkinson's disease\| PubMed ID: 22328911	2011
Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain. Neurobiology of aging\| PubMed ID: 25457558	2015
The longitudinal transcriptomic response of the substantia nigra to intrastriatal 6-hydroxydopamine reveals significant upregulation of regeneration-associated genes. PloS one\| PubMed ID: 25992874	2015
High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine. PloS one\| PubMed ID: 26222442	2015
Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration. PloS one\| PubMed ID: 26340267	2015
Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 28607168	2017
Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression. Scientific reports\| PubMed ID: 29180681	2017
Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease. Parkinsonism & related disorders\| PubMed ID: 29759928	2018
Parkinson's disease-linked knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 30842285	2019
Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats. Experimental neurology\| PubMed ID: 32387398	2020
Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits. Neurobiology of disease\| PubMed ID: 32422283	2020
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 33215284	2020
Striatal afferent BDNF is disrupted by synucleinopathy and partially restored by STN DBS. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 33472823	2021
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease. JCI insight\| PubMed ID: 33682798	2021
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease. Neuromodulation : journal of the International Neuromodulation Society\| PubMed ID: 34288271	2021
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. NPJ Parkinson's disease\| PubMed ID: 35610264	2022